APOE and depressive symptom measurement: Thus, it is highly probable that the deficit in synaptic strength and plasticity [46, 47], along with dysregulated BDNF–5-HT2A signaling, in ApoE4 carriers increases their risk of developing depression, which, in the presence of environmental stressors, can lead to the manifestation of clinical depression.